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Özet: Şizofrenide dirençli olguların oranı %20-25 olarak 
bildirilmektedir. Tedaviye direnç tanımı birçok otorite 
tarafından yapılmıştır. Genel kabul gören iki tanımdan 
biri, farklı atipik antipsikotikler ile en az dört-altı hafta 
süre ile iki veya üç kez tedavi uygulamasına yeterli yanıt 
alınamaması; diğeri ise iki farklı tipik veya atipik antip-
sikotik ilacın dört-altı hafta süre ile monoterapi olarak 
kullanıldığı, iki farklı tedavi denenmesine rağmen yeter-
siz yanıt olmasıdır. Dirençli olguların hastanede kalma 
süreleri uzundur. Ayrıca tüm harcamalar ve işlev kaybı 
düşünüldüğünde dirençli  olguların topluma maliyetle-
ri daha yüksektir. 60 yaşında, kadın hasta, Aralık 2013 
tarihinde oğlu ile geldiği acil servisten homicid riski ve 
tedavi reddi nedeni ile yatırıldı. Hastalığının 24 yaşında 
iken postpartum dönemde başladığı, şizofreni tanısı ile 
takip edildiği, 60 kez yatışı olduğu öğrenildi. Klozapin, 
haloperidol, amisülpirid, risperidon, olanzapin, aripip-
razol, ketiyapin, klorpromazin, sülpirid, zuklopentiksol, 
flufenazin, lityum ve  valproat yeterli doz ve sürede 
kullanılmasına; toplamda 342 seans EKT uygulanması-
na ve yanıt veya kısmi yanıt alınmasına rağmen uzun 
süreli işlevsellik ve iyilik hali sağlanamamıştır. En son 
yatışında klozapin 275 mg/gün, valproat 1000 mg/gün 
ile belirgin düzelme sağlandı. Tüm sağaltım çabalarına 
rağmen aşırı nüks ve sık yatışı olan şizofreni olgusu tar-
tışılmıştır.
Anahtar Kelimeler: Şizofreni, tedavi direnci, sosyal 
destek 
Abstract: It is reported that between 20% and 25% of 
patients have schizophrenia that is resistant to treat-
ment. The treatment resistance in schizophrenia is defi-
ned by many authorities. One of the generally accepted 
definitions is inadequate response despite treatment 
with different atypical antipsychotics, two or three ti-
mes at least four-six weeks; the other acceptable one 
is although the use of two different typical or atypical 
antipsychotics in monotherapy during four-six weeks, 
inadequate treatment response is obtained. Duratian 
of hospitalization in treatment resistant cases is longer. 
In addition, when considering all the expenses and loss 
of functions, the cost of resistant cases to society is hi-
gher. 60 years old, women patient. She was hospitali-
zed from emergency department where she came with 
his son, because of denial of treatment and homicidal 
intent. It is learned that age of onset was 24, disease 
began in a postpartum period, she was diagnosed with 
schizophrenia and she had 60 hospitalizations. Althou-
gh clozapine, haloperidol, amisulpiride, risperidone, 
olanzapine, aripiprazole, quetiapine, chlorpromazine, 
sulpiride, zuclopenthixol, fluphenazine, lithium and 
valproate were used adequate doses and time; a total 
of 342 ECT sessions were administered; response or 
partial response was achieved, she had not achieved 
long-term functioning and well-being. In the most re-
cent admission, she had significant improvement with 
clozapine 275 mg/day and valproat 1000 mg/day. Des-
pite all treatment efforts, schizophrenic patient with 
excessive admissions and frequent recurrences is dis-
cussed.
Keywords: Schizophrenia, treatment resistance, social 
support
INTRODUCTION
Lehman et al. defined treatment-resistant schizoph-
renia (TRS) as inadequate response despite treatment 
with different atypical antipsychotics, two or three ti-
mes at least four-six weeks1. One of the other accepted 
definition for TRS is persistence of symptomps after 
the administration of two different typical or atypical 
antipsychotics in monotherapy during four-six weeks2.
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When patients with acute schizophrenia are adminis-
tered an antipsychotic medication, approximately 50 
percent will improve to the extent that they will achieve 
a complete remission or experience only mild symp-
toms. The remaining 50 percent of patients improve, 
but still demonstrate variable levels of positive symp-
toms that are resistant to the medications. Some pa-
tients are so severely ill that they require chronic hospi-
talization. Others will respond to an antipsychotic with 
substantial suppression of their psychotic symptoms, 
but demonstrate persistent symptoms such as hallu-
cinations or delusions3. TRS remains common and ex-
pensive, despite availability of many treatment options, 
and contributes to a significant loss in patient’s quality 
of life. Although estimates in the literature vary greatly, 
TRS has huge medical costs4,5.
AIM
In this case report, a sixty-year-old female with schi-
zophrenia was presented. She had 60 hospitalizations 
and 342 ECT sessions in 36 years.
CASE
She is a sixty-year-old female with schizophrenia hos-
pitalized for dangerous behaviors associated with a set 
of crystallized delusions and auditory hallucinations. 
Her first psychotic symptoms started at the age of 24 
in a postpartum period. She was diagnosed as postpar-
tum psychosis. Her second hospitalization was in 1984. 
She was applied three ECT sessions and was dischar-
ged with diagnose of atypical psychosis. She was hos-
pitalized three times between 1984 and 2001 with se-
rious homicidal and violence behaviors as burning the 
houses, attacking with a knife to her children. She had 
a total 21 ECT sessions in these 3 hospitalizations beca-
use of her risky behaviors. Her sixth hospitalization was 
in 2001 with similar complaints. She was diagnosed as 
schizoaffective disorder. Until 2006, she had 22 more 
hospitalizations with different diagnoses including ma-
nic episodes with psychotic features and rapid cycling, 
schizoaffective disorder. In these 22 hospitalizations, 
216 ECT sessions were administered and the drugs 
like haloperidol, amisulpiride, risperidone, olanzapi-
ne, aripiprazole, quetiapine, chlorpromazine, sulpiride, 
zuclopenthixol, fluphenazine, lithium, valproate, clona-
zepam, diazepam were used in adequate doses and du-
ration. She had no long-term adequate functioning and 
well-being. None of the family members wanted to take 
care of the patient because of her serious persecutory 
delusions and behaviors. She had 32 hospitalizations 
with same complaints and was diagnosed schizophre-
nia between 2006-2013. She had 102 ECT sessions du-
ring this time. Clozapine was firstly used in her fortieth 
hospitalization in 2008 but she refused to take drugs 
after discharge. In most recent admission, she was hos-
pitalized from emergency department because of acu-
te psychotic symptoms, refusal of treatment and homi-
cidal thoughts. She was initiated on haloperidol 20 mg/
day, biperiden 10 mg/day, chlorpromazine 50 mg/day. 
After 2 weeks, it was seen that persecutive delusions 
and auditory hallucinations persisted although her agg-
ression and disruptive behaviors decreased. She was 
started clozapine. Two weeks after initiation the dose 
had been titrated to 200 mg. Noticeable improvement 
was produced in her delusions and hallucinations. Her 
dose was further increased up to 275 mg/day under 
close control and valproate 1000 mg/day was added. 
Her PANSS decreased 40% after initiation of clozapine. 
After her family members were invited to hospital and 
educated about schizophrenia, symptoms, relapse and 
medications, she was discharged with clozapine 275 
mg/day and valproate 1000 mg/day. Although her fa-
mily did not get in contact with health care team after 
discharge, medical records showed that she hadn’t any 
hospitalizations.
DISCUSSION
In this case report, a treatment-resistant schizophrenia 
patient with 60 hospitalizations is presented. It is inte-
resting to note that she had frequent hospital admissi-
ons after 2001, although she achieved response in ear-
lier hospitalizations. When discussed with family, all of 
the family members were seen in shame, helplessness 
and frustration. Health care workers also can share si-
milar feelings like hopelessness and anger during treat-
ment of extremely challenging cases. Despite sixty hos-
pitalizations, family members didn’t receive a complete 
psychoeducation. The patient’s treatment is limp after 
discharge and process inevitably ends in hospital. It is 
known that family members had a important role in 
providing care for patients with mental illness. Ossman 
et. all stated that the duration of hospitalization had 
a significant negative correlation with functional sup-
port properties and frequency of contact6 Caregivers 
of mentally ill patients generally distinguishes between 
objective and subjective burden. Objective burden refers 
patients’ disruptive behaviors and negative symptoms. 
Subjective burden refers to the emotional reactions of 
caregivers’ to the situation7. In literature it is reported 
that family psychoeducation interventions had reduc-
tions in illness relapse, negative symptoms and inpa-
tient service utilization8. Modifications to multiple family
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group treatment and family interventions may more 
effectively deal with the burden that could result from 
this increased awareness9. Most patients with schizoph-
renia will benefit from a combination of pharmacothe-
rapy and psychosocial interventions. Therefore, psy-
choeducation as a part of treatment can be frequently 
ignored by medical personal and it unfortunately ends 
in under-treatment and treatment resistance. The use 
of “resistance” suggests that nothing can be done to 
improve schizophrenic symptoms.   The term of “resis-
tance” is better viewed as “incomplete recovery”, a term 
reflecting the potential for newly improved therapeutic 
outcomes10. Social support and psychoeducation for 
family should be taken into consideration as therapeu-
tic methods. Bustillo et al.reported that family therapy 
and assertive community treatment have effects on the 
prevention of psychotic relapse and rehospitalization11. 
Yildirim et al. states that after psychoeducation, signi-
ficant difference was found between the experimental 
group and control group in terms of family functioning 
of caregivers and it was determined that medication 
noncompliance rate reduced from 40.6% to 21.9%12. 
Also, Zhang et al reported that compared with the cont-
rol group (from 26% reduced to 23%), the experimental 
group whose family had psychoeducation (from 32% 
reduced to 18%) showed a reduction in annual relapse 
rates13.Psychosocial treatments may also improve the 
response to pharmacotherapy by improving medicati-
on compliance. This was suggested in a study in which 
patients received a form of family treatment that also 
encouraged medication compliance. In addition, spe-
cific compliance-focused group sessions have been 
shown to be helpful. Other studies have indicated that 
psychosocial treatments, particularly family treatment, 
may decrease the amount of stress that the patient ex-
periences within the family, and that this, in turn, dec-
reases the amount of antipsychotic medication requi-
red by the patient. Providing better social support and 
educating the family can provide better care to the pa-
tient and improve the prognosis in a disabling disorder 
like schizophrenia
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